Description

mRNA is a long, polymeric molecule, composed of four different building blocks called nucleotides. In the last decade mRNA has progressed into a promising new class of medicine, with the potential to treat a wide variety of diseases with high unmet medical needs. The global mRNA vaccines & therapeutics market is set to grow by US$ 13.12 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period, according to data and analytics company StrategyHelix. Rising consumer disposable income and living standards, rise in the geriatric population and growing prevalence of chronic diseases and rare disorders, growing cases of COVID-19 globally, favorable regulatory environment are expected to boost the market growth in the coming years.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for mRNA vaccines & therapeutics. The global mRNA vaccines & therapeutics market is segmented on the basis of product, region. By product, it is categorized into mRNA vaccines, and mRNA therapies. The mRNA vaccines segment held the largest market share in 2020. By region, the mRNA vaccines & therapeutics market is divided into North America, Asia Pacific, Europe, and Rest of the World (ROW).

The mRNA therapies market is further segmented into infectious diseases, oncology, rare disorders, and others. Among them, infectious diseases segment held the largest market share in 2020.

The report has profiled some of the key players of the market such as Arcturus Therapeutics Holdings Inc., BioNTech SE, CureVac N.V., ethris GmbH, Daiichi Sankyo Company Limited, GlaxoSmithKline plc, Moderna Inc., Translate Bio Inc., Johnson & Johnson, GreenLight Biosciences Inc., eTheRNA immunotherapies NV.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the mRNA vaccines & therapeutics market to help drive informed decision making for industry executives, policy makers, academic, and analysts.


Report Scope

Product: mRNA vaccines, and mRNA therapies
Region: North America, Asia Pacific, Europe, and Rest of the World (ROW)
Years Considered: this report covers the period 2017 to 2027


Key Benefits for Stakeholders

Get a comprehensive picture of the global mRNA vaccines & therapeutics market
Pinpoint growth sectors and trends for investment
Understand what the future of the global mRNA vaccines & therapeutics market looks like
Identify the competitive landscape and window of opportunity


Table of Contents

1. Market Definition
2. Research Methodology
3. Market Data & Outlook
3.1 Market Value
3.2 Market Value Forecast
4. mRNA Vaccines & Therapeutics Market by Product
4.1 Mrna Vaccines
4.2 Mrna Therapies
5. mRNA Vaccines & Therapeutics Market by Region
5.1 North America
5.2 Asia Pacific
5.3 Europe
5.4 Rest Of The World (Row)
6. Company Profiles
6.1 Arcturus Therapeutics Holdings Inc.
6.2 BioNTech SE
6.3 CureVac N.V.
6.4 ethris GmbH
6.5 Daiichi Sankyo Company, Limited
6.6 GlaxoSmithKline plc
6.7 Moderna, Inc.
6.8 Translate Bio, Inc.
6.9 Johnson & Johnson
6.10 GreenLight Biosciences, Inc.
6.11 eTheRNA immunotherapies NV
7. Appendix
7.1 About StrategyHelix
7.2 Disclaimer


USD 2,750

Product Type

Industry Briefing

Release Date

5 November 2021

Region

Global

Pages

26

REQUEST SAMPLE

Global mRNA Vaccines & Therapeutics Market 2021

Please fill out our form and we will get back to you.

CUSTOM RESEARCH

Global mRNA Vaccines & Therapeutics Market 2021

Please fill out our form and we will get back to you.

login